#maraviroc

What does the future hold for new pre-exposure prophylaxis (PrEP) against HIV, including long-acting injectables and less toxic drugs?

A weekly injection of an HIV antibody boasted a 98 percent success rate among participants in a small trial.

Levels of Selzentry (maraviroc) in vaginal and rectal tissues following a single dose were not high enough to be effective as PrEP in a recent...

An element of semen both lowers the effectiveness of many HIV microbicides and enhances the virus’s infectiousness, possibly explaining why re...

HIV-positive African Americans may not be able to maintain effective drug levels of Selzentry (maraviroc) at the antiretroviral’s standard dos...

In the future, women’s HIV prevention efforts may be as familiar a process as inserting a tampon, thanks to research showing that water-solubl...

Selzentry failed in a head-to-head with Truvada as a first-line treatment for HIV when each were paired with Prezista.

A majority of people taking antiretrovirals to treat HIV could switch to newer regimens with improved side effect profiles.

After many years of failures, recent studies have moved researchers closer to a form of HIV prevention that women can use discreetly.

He had a malfunctioning CCR5 receptor on his CD4 cells.

For the first time, researchers have documented the microscopic structure of the CCR5 coreceptor, which HIV binds to in order to begin its ent...

How you can find health insurance coverage for 2014.

Beginning a five-drug antiretroviral cocktail during early phase of HIV infection shows promise to fight the development of viral reservoir.

The addition of Selzentry and Isentress to a standard HIV regimen rapidly and significantly reduces the likelihood of low level shedding of th...

The HIV antiretroviral Selzentry (maraviroc) combats the potentially lethal pathogen Staphylococcus aureus.

A nucleoside reverse transcriptase inhibitor (NRTI)-sparing regimen containing Selzentry (maraviroc) and Norvir (ritonavir)-boosted Reyataz (a...